VC
SBBP

Vivo Capital’s Strongbridge Biopharma plc. SBBP Stock Holding History

Vivo Capital’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-914,062
Closed -$4.55M – 52
2019
Q1 		$4.55M Buy
+914,062
New +$4.5M 0.45% 39
2018
Q4 		– Sell
-918,132
Closed -$4.45M – 48
2018
Q3 		$4.45M Sell
918,132
-1,000,000
-52% -$5.12M 0.45% 35
2018
Q2 		$11.5M Hold
1,918,132
– – 1.48% 19
2018
Q1 		$17M Sell
1,918,132
-534,265
-22% -$4M 2.4% 12
2017
Q4 		$17.8M Sell
2,452,397
-510,248
-17% -$3.19M 3.81% 11
2017
Q3 		$20.4M Sell
2,962,645
-37,355
-1% -$258K 4.13% 7
2017
Q2 		$21.4M Hold
3,000,000
– – 5.4% 7
2017
Q1 		$14.3M Hold
3,000,000
– – 4.19% 8
2016
Q4 		$7.2M Buy
+3,000,000
New +$12.2M 2.37% 13

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vivo Capital's SBBP Position: Q2 2019 in Review

Vivo Capital sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2019, closing a stake of 914,062 shares — an estimated $4.55M sold.

Vivo Capital first reported a position in SBBP in Q4 2016 and held it in 9 quarters. The position peaked at $21.4M in Q2 2017. 58 funds tracked by Wall St. Rank hold SBBP as of Q2 2019.

  • Vivo Capital reported no remaining Strongbridge Biopharma plc. position as of Q2 2019 after selling out during the quarter.
  • Vivo Capital sold 914,062 Strongbridge Biopharma plc. shares in Q2 2019, an estimated $4.55M.
  • Vivo Capital first reported a position in Strongbridge Biopharma plc. in Q4 2016 and held it in 9 quarters.
  • Vivo Capital's Strongbridge Biopharma plc. position peaked at $21.4M in Q2 2017.
  • 58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2019.

Based on Vivo Capital's 13F filing for Q2 2019, filed 13 Aug 2019.